Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors with high prevalence
among adult populations and elevated costs for public health systems worldwide. Despite …

Accumulating evidence indicates that obesity is closely associated with an increased risk of
metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and …

Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

Konjac glucomannan (KGM) is a dietary fiber hydrocolloidal polysaccharide isolated from
the tubers of Amorphophallus konjac. Over the last few decades, the purified KGM has been …

Introduction Women with polycystic ovary syndrome (PCOS) have increased risk of
metabolic syndrome. The relative contribution of clinical, demographic or biochemical …

The existing term non-alcoholic fatty liver disease (NAFLD) has raised substantial concerns
due to its inherent disadvantages of using exclusionary diagnostic criteria and the …

Obesity is a chronic disease with a high prevalence in Chile and all over the world. It is
defined by an excessive accumulation of body fat content which according to its magnitude …

Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Context: Irisin, a recently identified hormone, has been proposed to regulate energy
homeostasis and obesity in mice. Whether irisin levels are associated with risk of the …

Fat tissue, frequently the largest organ in humans, is at the nexus of mechanisms involved in
longevity and age‐related metabolic dysfunction. Fat distribution and function change …